Neuroleptic hyperprolactinemia medicamentous correction
The article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/82 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The article discusses various aspects of the main approaches to the issue of correction of neuroleptic hyperprolactinemia. Based on the generalized scientific and practical experience, algorithms for corrective therapy with dopamine agonists - bromocriptine and cabergoline (Dostinex) are given. The data on indications and contraindications to prescribing therapy with these drugs are substantiated, as well as features of their side effects. |
|---|---|
| ISSN: | 2313-7053 2713-055X |